Studies of dose-escalated external beam radiation therapy (EBRT) and low dose rate
brachytherapy (LDR-BT) have shown excellent rates of tumor control and cancer specific …

For patients with unfavorable or high-risk prostate cancer, dose escalated radiation therapy
leads to improved progression free survival but attempts to deliver increased dose by …

Introduction: Patients with intermediate to high risk disease (prostate specific antigen
(PSA)≥ 10, Gleason score≥ 7, or clinical stage≥ T2b) suffer from poorer long-term …

Purpose Dose escalation using high-dose-rate brachytherapy (HDR-BT) is an established
treatment method for prostate cancer. First, long-term results were previously published …

Purpose To report the outcomes of our high-dose-rate brachytherapy (HDR-BT) boost
experience in localized prostate cancer treated with different combinations of radiation …

Results The median follow-up is 10 years from the date of the first LHRH injection. The 10-
and 15-year KM b-PFS (Phoenix) estimates were 85% and 80% for LDR-PB compared to …

BACKGROUND AND PURPOSE: High dose-rate (HDR) brachytherapy is most commonly
administered as a boost in two or more fractions combined with external beam radiotherapy …

Brachytherapy delivers the most conformal high dose radiotherapy possible to the prostate,
using either a low dose rate (LDR) or high dose rate (HDR) technique. It may be used either …

Purpose Dose escalation for prostate cancer can be achieved with a combination of external
beam radiotherapy (EBRT) and brachytherapy (BT) boost to increase local control. For high …

Purpose External beam radiation therapy (EBRT) with brachytherapy boost reduces cancer
recurrence in patients with prostate cancer compared with EBRT monotherapy. However …